IL6 and metabolic dysfunction-associated steatotic liver disease: Carulli et al. found that the IL-6 -174C variant was significantly more prevalent in NAFLD than in healthy subjects, was associated with increased fasting insulin and HOMA-IR, and was an independent predictor of NAFLD and NASH [218].